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Abstract
BACKGROUND: At the present moment, the etiological diagnosis of SARS-CoV-2 is based on the polymerase chain 
reaction (PCR). False negative cases are increasingly reported in several studies using reverse transcription-PCR 
(RT-PCR). For example, the positive rate of RT-PCR for throat swabs was reported to be about 60% in early stage 
of COVID-19.
AIM: We aimed to present metagenomic next-generation sequencing (mNGS) as a potential tool to detect pathogens.
METHODS: In the recent year, mNGS is shown the potential to detect pathogens without the need of hypothesis 
guided approach and is proven to be highly effective.
RESULTS: A recent prospective study in the United States compared the diagnostic performance of routine 
diagnostic tests with mNGS and showed that mNGS detected a bacteria or virus in the CSF of 13 of 58 patients 
presenting with meningoencephalitis who were negative for or not assessed with routine diagnostic test including 
PCR. NGS also has the advantage to cover entire viral genomes.
CONCLUSION: As viral metagenomics has significantly improved in recent years and become more cost effective, 
we think that a change in the approach toward a shot-gun metagenomic testing should be explored and could 
potentially aid the diagnosis of COVID-19 cases and the management of this pandemic.
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Dear editor,
We, along with the international community, are 
gravely concerned by the recent international outbreak 
of the coronavirus SARS-CoV-2 (coronavirus disease 
2019; previously 2019-nCoV). SARS-CoV-2 was 
declared a pandemic by the World Health Organization 
(WHO) on March 13, 2020, following spread from the 
Hubei Province of the People’s Republic of China. 
Europe has now overtaken China, becoming the 
epicenter of the infection and the incidence of new 
cases plus deaths from COVID-19 in Italy is now greater 
than in China. To date, 19 genomic strains of the virus 
have been identified in infected patients [1].
The WHO recommends a combination of 
measures to tackle spread of the virus including 
rapid diagnosis, immediate isolation of cases, 
rigorous tracking, and precautionary self-isolation of 
close contacts [2]. Rapid diagnosis has been key in 
managing this pandemic and has worked effectively 
in many countries such as South Korea and in China 
which have seen a decline in the number of new 
infections. However, many individuals with SARS-
CoV-2 infection remain undiagnosed because testing 
efforts are currently ineffective or not widely available.
At the present moment, the etiological diagnosis 
of SARS-CoV-2 is based on the polymerase chain 
reaction (PCR). Both the WHO and the US centers 
for disease control and prevention, along with other 
national and international scientific organizations, have 
released detailed information for in-house development 
of reverse transcription-PCR (RT-PCR) tests. These 
are being implemented by many reference laboratories 
worldwide and are undergoing clearance by many 
regulatory agencies. Unfortunately, false negative 
cases are increasingly reported in several studies 
using RT-PCR [3]. For example, the positive rate of 
RT-PCR for throat swabs was reported to be about 
60% in the early stage of COVID-19. This is an area of 
major concern and has huge impacts on the efficacy of 
testing and isolation processes. False negative RT-PCR 
patients are less likely isolate, propagating viral spread 
and means the results of RT-PCR should be interpreted 
with caution [4].
However, an alternative to RT-PCR may 
already exist. In the recent year, metagenomic 
next-generation sequencing (mNGS) is shown the 
potential to detect pathogens without the need of 
hypothesis guided approach [5] and is proven to be 
highly effective [5], [6], [7]. As an example, a recent 
prospective study in the United States compared the 
diagnostic performance of routine diagnostic tests with 
mNGS and showed that mNGS detected a bacteria or 
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virus in the CSF of 13 of 58 patients presenting with 
meningoencephalitis who were negative for or not 
assessed with routine diagnostic test including PCR. 
NGS also has the advantage to cover entire viral 
genomes. This carries the added benefit of helping 
to understand if individual mutations or strain may 
be responsible for the variable pattern of spread and 
illness we are witnessing worldwide.
As viral metagenomics has significantly 
improved in recent years and becomes more cost 
effective, we think that a change in the approach toward 
a shot-gun metagenomic testing should be explored 
and could potentially aid the diagnosis of COVID-19 
cases and the management of this pandemic.
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